A randomised clinical effectiveness trial of a bipolar disorder clinic
Not Applicable
Completed
- Conditions
- Bipolar DisorderMental Health - Other mental health disorders
- Registration Number
- ACTRN12611000961943
- Lead Sponsor
- niversity of Otago, Christchurch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Patients with a diagnosis of bipolar disorder discharged from specialty mental health services.
Exclusion Criteria
Exclusion criteria will be the primary diagnosis of a serious mental disorder such as schizophrenia or severe alcohol and drug dependence
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ower rates of relapse at 18 months because of better self-management than patients randomised to general practice. The primary outcome measure is the Longitudinal Interval Follow-up Evaluation.[18 months]
- Secondary Outcome Measures
Name Time Method the Bipolar Disorder Clinic will prove more cost-effective than usual care over the 18 month intervention period. 1)A cost analysis of service use with all direct costs (inpatient admission; outpatient admission, emergency department visit, GP visit) taken into account. Data will be collected from computerised patient records for which an electronic protocol has been developed. All unit costs based on aggregated cost estimates derived from averaged CDHB data will be calculated from randomization for both intervention and control groups. In addition the costs associated with the intervention (therapist time and psychiatrist time) will be calculated in 30 minute units.[18 months]